#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15112	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2042	732.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	868	C	818	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15112	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2042	732.3	0	HET	.	.	.	C207T	.	207	207	C	433	433	C	873	C,T	632,175	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15112	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2042	732.3	0	HET	.	.	.	C451T	.	451	451	C	677	677	C	854	C,T	394,407	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27410	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	753.8	0	.	n	.	0	T695C	SNP	695	695	T	1018	1018	C	896	C	847	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27410	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	753.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2294	2294	C	831	C	775	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27410	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	753.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2368	2368	A	840	A,G	787,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27410	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	753.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2920	2920	C	874	C,T	824,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27410	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	753.8	0	HET	.	.	.	A1638G	.	1638	1638	A	1961	1961	A	875	A,G	448,375	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2102	folP	855	855	100.0	folP.l15.c4.ctg.1	1639	127.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1058	1060	AGC	201;204;205	A;G;C	189;193;193	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5610	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	164.3	1	SNP	p	S91F	1	.	.	271	273	TTC	578	580	TTC	188;188;189	T;T;C	176;174;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5610	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	164.3	1	SNP	p	D95G	1	.	.	283	285	GGC	590	592	GGC	184;186;187	G;G;C	169;169;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5610	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	164.3	1	SNP	p	G95N	0	.	.	283	285	GGC	590	592	GGC	184;186;187	G;G;C	169;169;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1742	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1499	115.7	1	SNP	p	G45D	0	.	.	133	135	GGC	573	575	GGC	207;208;206	G;G;C	198;197;194	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	948	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1057	89.0	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	207	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	177.2	1	SNP	p	D86N	0	.	.	256	258	GAC	534	536	GAC	182;181;183	G;A;C	171;166;172	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	177.2	1	SNP	p	R87I	0	.	.	259	261	CGT	537	539	CGT	184;184;188	C;G;T	171;170;173	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	177.2	1	SNP	p	R87W	0	.	.	259	261	CGT	537	539	CGT	184;184;188	C;G;T	171;170;173	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	177.2	1	SNP	p	S87R	1	.	.	259	261	CGT	537	539	CGT	184;184;188	C;G;T	171;170;173	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	177.2	1	SNP	p	S88P	0	.	.	262	264	TCC	540	542	TCC	190;189;192	T;C;C	174;172;178	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4406	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2676	163.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1588	1590	GGC	197;195;195	G,T;G;C	182,1;177;179	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1234	1236	GCC	218;217;220	G;C;C	204;201;205	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1237	1239	ATG	221;223;223	A,G;T;G	204,1;206;205	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1249	1251	ACC	220;220;221	A;C;C	204;206;206	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1249	1251	ACC	220;220;221	A;C;C	204;206;206	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1750	1752	ACC	211;214;211	A;C;C,T	188;197;193,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1804	1806	GCG	193;193;190	G;C;G	183;185;180	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1804	1806	GCG	193;193;190	G;C;G	183;185;180	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1927	1929	GGT	168;166;169	G;G;T	149;149;152	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1936	1938	AGC	165;165;164	A;G;C	140;141;142	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2356	166.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1954	1956	CCG	134;136;132	C,CGG;C;GCCC,GGCCCCC	103,1;107;95,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5930	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3038	194.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1584	1586	CCG	225;224;221	C;C;G	201;207;195	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2076	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1665	122.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	159	C,T	142,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	A251V	NONSYN	751	753	GCG	62	64	GTA	42;42;42	G;T;A	36;36;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	S271T	NONSYN	811	813	TCG	122	124	ACT	67;65;65	A;C;T	62;60;61	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	128	130	GAT	47;45;45	G;A;T	44;42;42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	D276N	NONSYN	826	828	GAT	137	139	AAC	45;45;45	A;A;C	42;42;42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	N277H	NONSYN	829	831	AAC	140	142	CAC	45;45;46	C;A;C	41;41;42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	230	232	GAA	15;16;17	G;A;A	15;16;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	242	244	GCA	15;15;16	G;C;A	15;15;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	245	247	GAC	16;16;16	G;A;C	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	251	253	ATC	15;15;15	A;T;C	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	257	259	TCG	13;14;14	T;C;G	13;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	263	265	GCC	13;13;13	G;C;C	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	266	268	AGC	13;13;13	A;G;C	12;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	269	271	GCC	13;13;12	G;C;C	13;13;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	357	29.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	275	277	GTT	10;10;9	G;T;T	10;10;9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2740	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1696	160.5	1	SNP	p	G120K	1	.	.	358	360	AAG	683	685	AAG	216;217;219	A;A;G,C,A	209;212;206,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2740	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1696	160.5	1	SNP	p	N121D	0	.	.	361	363	AAC	686	688	AAC	216;214;214	A;A;C,A	206;207;202,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2740	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1696	160.5	1	SNP	p	A121N	1	.	.	361	363	AAC	686	688	AAC	216;214;214	A;A;C,A	206;207;202,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10502	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4967	211.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1164	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1096	105.2	1	SNP	p	V57M	1	.	.	169	171	ATG	467	469	ATG	220;222;222	A;T;G	205;209;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
